门诊全膝关节置换术围手术期阿片类药物处方模式的性别差异
这项回顾性队列研究利用2018至2021年全国数据库(18至64岁)和Medicare补充数据库(65岁及以上),分析门诊初次全膝关节置换术患者围手术期阿片类药物处方模式。结果显示,商业保险队列中男性围手术期吗啡毫克当量较高但亚急性和持续性阿片使用几率较低;Medicare队列中男性配药几率及吗啡毫克当量较高但亚急性使用几率较低。作者认为需进一步研究理解这些差异的机制和适当性。
要点
- 商业保险队列中男性围手术期吗啡毫克当量较女性高22.5(95%CI 12.30至32.79),亚急性阿片使用OR=0.77,持续性使用OR=0.84。
- Medicare队列中男性配药几率OR=1.18(95%CI 1.03至1.36),围手术期吗啡毫克当量OR=19.45(95%CI 0.60至38.29),亚急性使用OR=0.80。
- 作者认为需进一步研究理解观察到的差异机制和适当性,尤其女性术后持续阿片使用风险可能更高。
核心结论
- 门诊全膝关节置换术后,男性围手术期阿片类药物剂量较高,但术后继续使用阿片类药物的可能性较低。
- 作者认为需进一步研究理解这些观察差异的机制和适当性,尤其女性术后持续阿片使用风险可能更高。
研究设计与样本
- 回顾性队列研究,使用2018至2021年全国数据库(患者年龄18至64岁)和Medicare补充数据库(65岁及以上)。
- 识别接受门诊初次全膝关节置换术的患者,检查围手术期阿片处方配药、口服吗啡毫克当量处方量以及亚急性和持续性阿片使用。
- 采用多变量回归模型分别在商业保险和Medicare队列中检验性别(男性 versus 女性)与结局的关联,并调整协变量。
主要发现
- 商业保险队列(n=21,788;男性43.6%)中,性别与围手术期阿片处方配药无关联,但男性围手术期吗啡毫克当量较女性高22.5(95%CI 12.30至32.79,P<0.001)。
- 商业保险队列中,男性亚急性阿片使用几率较女性低(OR=0.77,95%CI 0.71至0.83,P<0.001),持续性阿片使用几率也较低(OR=0.84,95%CI 0.76至0.94,P=0.002)。
- Medicare队列(n=7,518;男性37.6%)中,男性围手术期阿片处方配药几率较女性高(OR=1.18,95%CI 1.03至1.36,P=0.02),围手术期吗啡毫克当量也较高(OR=19.45,95%CI 0.60至38.29,P=0.04)。
- Medicare队列中,男性亚急性阿片使用几率较女性低(OR=0.80,95%CI 0.68至0.93,P=0.005)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sex-based differences in opioid prescribing following total knee arthroplasty (TKA) have been reported, though little is known about outpatient TKA or older adults. This study examined sex differences in perioperative opioid prescribing patterns among patients undergoing outpatient TKA. METHODS: This retrospective cohort study utilized 2018 to 2021 data from a national database (patient age 18 to 64 years) and the Medicare Supplemental (ages 65 plus years) database. We identified patients undergoing outpatient primary TKA and examined perioperative opioid prescription fills, oral morphine milligram equivalents (MMEs) prescribed, and subacute and persistent opioid use. Multivariable regression models examined the association between sex (men versus women) and outcomes, adjusting for covariates, separately in the commercial and Medicare cohorts. RESULTS: In the commercial cohort (n = 21,788; 43.6% men), there was no association between sex and filling a perioperative opioid prescription, but men had higher perioperative MMEs (22.5, 95% confidence interval (CI): 12.30 to 32.79, P < 0.001) and lower odds of subacute (odds ratio (OR) = 0.77, 95% CI: 0.71 to 0.83, P < 0.001) and persistent (OR = 0.84, 95% CI: 0.76 to 0.94, P = 0.002) opioid use compared to women. In the Medicare cohort (n = 7,518; 37.6% men), men had increased odds of filling a perioperative opioid prescription (OR = 1.18, 95% CI: 1.03 to 1.36, P = 0.02) and higher perioperative MMEs (OR = 19.45, 95% CI: 0.60 to 38.29, P = 0.04), as well as lower odds of subacute opioid use (OR = 0.80, 95% CI: 0.68 to 0.93, P = 0.005). CONCLUSIONS: Following outpatient TKA, men were prescribed higher perioperative opioid doses, but were less likely to continue opioids postoperatively. Future research is needed to understand the mechanisms and appropriateness of these observed differences, particularly for women who may be at higher risk for continued postoperative opioid use.
引用
- Park J, Sabo GC, Jain M, et al. Differences by Sex in Perioperative Opioid Prescription Patterns for Outpatient Total Knee Arthroplasty. J Arthroplasty. 2025. PMID: 40848812. doi:10.1016/j.arth.2025.08.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。